Abstract

Purpose: Sevoflurane is the most commonly used anesthetic agent for surgery. However, it is associated with deficiency in learning and memory abilities. The study was aimed at investigating the role of nerve growth factor (NGF) in sevoflurane anesthesia-induced nerve injury.Methods: RT-qPCR assay was applied to measure expressions of NGF, miR-98-5p and other factors related to apoptosis. CCK-8 assay was used for detecting cell viability while luciferase reporter assay was employed to measure binding condition between miR-98-5p and NGF. Expressions of proteins in PI3K/AKT/mTOR signaling pathway was measured with western blot.Results: Sevoflurane reduced cell viability of RGC-5 cells, promoted apoptosis and reduced the expression of NGF. In sevoflurane-induced RGC-5 cells, over-expression of NGF promoted cell viability with reduced apoptosis. Also, there was reduction in the protein expression of PI3K/AKT/mTOR signaling pathway by sevoflurane, while up-regulation of NGF promoted the expressions of these proteins. In the presence of PI3K inhibitor, reduction cell viability was reduced but apoptosis increased. Luciferase reporter assay detected MiR-98-5p as the target gene of NGF and its overexpression restored high cell viability in the over-expressed NGF. The rate of apoptosis and expressions of proteins was also restored with up-regulation of miR-98-5p.Conclusion: Sevoflurane caused damage to nerve cells, while over-expression of NGF reduced the injury through PI3K/AKT/mTOR signaling pathway and suppression of miR-98-5p.
 Keywords: Nerve growth factor, Sevoflurane, Nerve injury, Anesthesia, miR-98-5p

Highlights

  • The purpose of this study was to investigate the role of nerve growth factor (NGF) in sevoflurane anesthesia-induced nerve injury

  • RGC-5 cell line was selected for measuring the functions of sevoflurane

  • By comparing RGC-5 in normal condition with those exposed to sevoflurane, cell viabilities in exposed group were significantly lower than those in normal condition, which suggested that sevoflurane could reduce proliferation of nerve cells

Read more

Summary

Introduction

Anesthesia is commonly used for surgery. It is a reversible, drug-induced condition associated with loss of consciousness, amnesia, analgesia and dyskinesia. Regan in 1968 and its pharmacological action, physicochemical and toxicological properties were reported in 1975 by Willin et al After that, it was adopted for clinical application in 1990 in Japan as anesthetic agent

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call